Page last updated: 2024-11-05

tiopronin and Coronary Disease

tiopronin has been researched along with Coronary Disease in 10 studies

Tiopronin: Sulfhydryl acylated derivative of GLYCINE.

Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19906 (60.00)18.7374
1990's3 (30.00)18.2507
2000's1 (10.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lucats, L1
Chalvignac, V1
Bizé, A1
Monnet, X1
Zini, R1
Hittinger, L1
Berdeaux, A1
Ghaleh, B1
Widman, SC1
Liang, CS1
Schenk, EA1
Hood, WB1
Patterson, E1
Tsao, PS1
Lefer, AM1
Beyersdorf, F2
Fuchs, J5
Eberhardt, B1
Stauder, M1
Satter, P1
Zimmer, G5
Mainka, L1
Bereiter-Hahn, J1
Myers, ML1
Bolli, R1
Lekich, RF1
Hartley, CJ1
Roberts, R1

Other Studies

10 other studies available for tiopronin and Coronary Disease

ArticleYear
Rapid ventricular pacing induces delayed cardioprotection against myocardial stunning.
    Journal of molecular and cellular cardiology, 2005, Volume: 39, Issue:6

    Topics: Animals; Cardiac Pacing, Artificial; Coronary Circulation; Coronary Disease; Dogs; Heart Ventricles;

2005
Contraction band necrosis: its modification by the free radical scavenger N-2-mercaptopropionyl glycine.
    Journal of cardiovascular pharmacology, 1994, Volume: 24, Issue:5

    Topics: Animals; Blood Pressure; Coronary Circulation; Coronary Disease; Disease Models, Animal; Dogs; Femal

1994
Coronary vascular injury following transient coronary artery occlusion: prevention by pretreatment with deferoxamine, dimethylthiourea and N-2-mercaptoproprionyl glycine.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 266, Issue:3

    Topics: Animals; Capillary Permeability; Coronary Disease; Coronary Vessels; Deferoxamine; Dogs; Lipid Perox

1993
Time course and mechanism of endothelial dysfunction in isolated ischemic- and hypoxic-perfused rat hearts.
    The American journal of physiology, 1990, Volume: 259, Issue:6 Pt 2

    Topics: Animals; Coronary Disease; Endothelium, Vascular; Heart; Humans; Hypoxia; In Vitro Techniques; Male;

1990
Myocardial protection by 2-mercaptopropionylglycine during global ischemia in dogs.
    Arzneimittel-Forschung, 1989, Volume: 39, Issue:1

    Topics: Adenosine Triphosphatases; Animals; Coronary Disease; Dogs; Fluorescent Dyes; Mitochondria, Heart; O

1989
2-Mercaptopropionylglycine and related compounds in treatment of mitochondrial dysfunction and postischemic myocardial damage.
    Arzneimittel-Forschung, 1985, Volume: 35, Issue:9

    Topics: Adenosine Triphosphatases; Aging; Amino Acids, Sulfur; Animals; Cattle; Coronary Disease; Diamide; F

1985
31P-NMR spectroscopic investigations and mitochondrial studies on the cardioprotective efficiency of 2-mercaptopropionylglycine.
    Biochemical pharmacology, 1986, Dec-15, Volume: 35, Issue:24

    Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Amino Acids, Sulfur; Animals; Coronary Disease; F

1986
A novel cardioprotective regimen for improvement of inner mitochondrial membrane function after ischemic stress.
    Arzneimittel-Forschung, 1987, Volume: 37, Issue:9

    Topics: Adenosine Triphosphatases; Amino Acids, Sulfur; Animals; Coronary Circulation; Coronary Disease; Fem

1987
A multiparameter analysis of the perfused rat heart: responses to ischemia, uncouplers and drugs.
    Cell biochemistry and function, 1987, Volume: 5, Issue:4

    Topics: Adenosine Triphosphate; Animals; Coronary Disease; Female; Fluorescent Dyes; Heart; Hypoxia; In Vitr

1987
N-2-mercaptopropionylglycine improves recovery of myocardial function after reversible regional ischemia.
    Journal of the American College of Cardiology, 1986, Volume: 8, Issue:5

    Topics: Amino Acids, Sulfur; Animals; Constriction; Coronary Circulation; Coronary Disease; Dogs; Drug Evalu

1986